| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 333,873 | 361,212 | 359,535 | | Cost of Revenue | 257,071 | 269,751 | 256,019 | | | Gross Profit | 76,802 | 91,461 | 103,516 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 18,503 | 23,073 | 30,432 | | Non Recurring | 377,630 | 36,373 | 4 | | Others | 14,338 | 14,451 | 13,338 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (333,669) | 17,564 | 59,742 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 832 | 129 | (10,316) | | Earnings Before Interest And Taxes | (333,496) | 17,564 | 46,285 | | Interest Expense | 25,551 | 34,837 | 43,160 | | Income Before Tax | (359,047) | (17,273) | 3,125 | | Income Tax Expense | (64,027) | (3,324) | 2,015 | | Minority Interest | (5,316) | (5,230) | (4,577) | | | | Net Income From Continuing Ops | (300,336) | (19,179) | (3,467) | | | Non-recurring Events | | Discontinued Operations | 67 | 17,829 | 117,048 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (300,269) | (1,350) | 113,581 | | Preferred Stock And Other Adjustments | (8,933) | (8,984) | (8,984) | | | Net Income Applicable To Common Shares | ($309,202) | ($10,334) | $104,597 |
|
1.48% Nasdaq 
Income Statement
